Lmt Avocats at Substipharm’s side
Cristian Rawlins and Charline Mathé, as members of the corporate team of Lmt Avocats assisted Substipharm in the acquisition of the rights held by Daiichi Sankyo in Europe, the United Kingdom, Switzerland and Turkey in Efient product, a drug indicated for the prevention of atherothrombotic events in patients with Acute Coronary Syndrome (ACS).